Barclays’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Buy |
199,530
+58,346
| +41% | +$128K | ﹤0.01% | 3101 |
|
|
2025
Q1 | $164K | Sell |
141,184
-40,054
| -22% | -$46.5K | ﹤0.01% | 3437 |
|
|
2024
Q4 | $229K | Buy |
181,238
+2,731
| +2% | +$3.45K | ﹤0.01% | 3453 |
|
|
2024
Q3 | $607K | Buy |
178,507
+56,986
| +47% | +$194K | ﹤0.01% | 2878 |
|
|
2024
Q2 | $567K | Sell |
121,521
-23,202
| -16% | -$108K | ﹤0.01% | 2463 |
|
|
2024
Q1 | $1.07M | Sell |
144,723
-134,714
| -48% | -$1,000K | ﹤0.01% | 2355 |
|
|
2023
Q4 | $2.83M | Buy |
279,437
+4,421
| +2% | +$44.8K | ﹤0.01% | 1920 |
|
|
2023
Q3 | $2.15M | Sell |
275,016
-24,270
| -8% | -$189K | ﹤0.01% | 1623 |
|
|
2023
Q2 | $2.46M | Buy |
299,286
+24,164
| +9% | +$199K | ﹤0.01% | 1608 |
|
|
2023
Q1 | $1.99M | Sell |
275,122
-165,279
| -38% | -$1.2M | ﹤0.01% | 1657 |
|
|
2022
Q4 | $3.91M | Buy |
440,401
+140,174
| +47% | +$1.24M | ﹤0.01% | 1250 |
|
|
2022
Q3 | $3.68M | Buy |
300,227
+278,208
| +1,263% | +$3.41M | ﹤0.01% | 1277 |
|
|
2022
Q2 | $261K | Sell |
22,019
-9,313
| -30% | -$110K | ﹤0.01% | 2997 |
|
|
2022
Q1 | $596K | Sell |
31,332
-63,162
| -67% | -$1.2M | ﹤0.01% | 2675 |
|
|
2021
Q4 | $2.51M | Buy |
94,494
+3,755
| +4% | +$99.7K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $3.73M | Buy |
90,739
+27,145
| +43% | +$1.11M | ﹤0.01% | 1416 |
|
|
2021
Q2 | $3.6M | Sell |
63,594
-40,923
| -39% | -$2.32M | ﹤0.01% | 1379 |
|
|
2021
Q1 | $4.39M | Buy |
104,517
+80,652
| +338% | +$3.39M | ﹤0.01% | 1281 |
|
|
2020
Q4 | $1.67M | Sell |
23,865
-23,093
| -49% | -$1.62M | ﹤0.01% | 1686 |
|
|
2020
Q3 | $1.32M | Sell |
46,958
-3,973
| -8% | -$111K | ﹤0.01% | 1754 |
|
|
2020
Q2 | $1.51M | Buy |
50,931
+5,820
| +13% | +$172K | ﹤0.01% | 1664 |
|
|
2020
Q1 | $896K | Sell |
45,111
-28,527
| -39% | -$567K | ﹤0.01% | 1795 |
|
|
2019
Q4 | $2.18M | Buy |
73,638
+18,260
| +33% | +$541K | ﹤0.01% | 1818 |
|
|
2019
Q3 | $1.26M | Buy |
55,378
+22,979
| +71% | +$522K | ﹤0.01% | 2109 |
|
|
2019
Q2 | $802K | Buy |
32,399
+18,653
| +136% | +$462K | ﹤0.01% | 2474 |
|
|
2019
Q1 | $336K | Sell |
13,746
-19,618
| -59% | -$480K | ﹤0.01% | 2795 |
|
|
2018
Q4 | $759K | Buy |
33,364
+15,183
| +84% | +$345K | ﹤0.01% | 2006 |
|
|
2018
Q3 | $579K | Buy |
18,181
+3,994
| +28% | +$127K | ﹤0.01% | 2567 |
|
|
2018
Q2 | $509K | Sell |
14,187
-25,552
| -64% | -$917K | ﹤0.01% | 2271 |
|
|
2018
Q1 | $1.32M | Buy |
39,739
+23,426
| +144% | +$776K | ﹤0.01% | 1615 |
|
|
2017
Q4 | $502K | Buy |
16,313
+3,510
| +27% | +$108K | ﹤0.01% | 2092 |
|
|
2017
Q3 | $307K | Buy |
12,803
+12,546
| +4,882% | +$301K | ﹤0.01% | 2174 |
|
|
2017
Q2 | $4K | Sell |
257
-1,362
| -84% | -$21.2K | ﹤0.01% | 3564 |
|
|
2017
Q1 | $37K | Sell |
1,619
-487
| -23% | -$11.1K | ﹤0.01% | 3192 |
|
|
2016
Q4 | $34K | Buy |
2,106
+1,962
| +1,363% | +$31.7K | ﹤0.01% | 2945 |
|
|
2016
Q3 | $2K | Buy |
+144
| New | +$2K | ﹤0.01% | 3591 |
|
|
2016
Q2 | – | Sell |
-24,240
| Closed | -$824K | – | 3654 |
|
|
2016
Q1 | $824K | Buy |
+24,240
| New | +$824K | ﹤0.01% | 1490 |
|